7 April 2020

The Chemical Immunology group from Martijn Verdoes, theme Nanomedicine, joined forces with two Organic Chemistry groups (Jeroen Codee and Dima Filippov) and a Chemical Biology group (Sander van Kasteren) from Leiden University, and Immunology groups at the AmsterdamUMC (Yvette van Kooyk) and the LUMC (Ferry Ossendorp) to form a consortium to develop new cancer vaccines.

Funding for this consortium was granted by the Institute for Chemical Immunology (ICI). Five PhD candidates will work in close collaboration to synthesize multimodal vaccine conjugates to specifically deliver tumor epitopes and immunomodulating adjuvants to dendritic cells with the aim to elicit specific T cell responses. Using state-of-the-art chemical strategies and super-resolution imaging techniques, conjugates bearing bioorthogonal trackable epitopes will be characterized at cell biological level.

This will provide valuable structure-activity relationship data when correlated to in vitro and in vivo immunological outcome, which will allow the consortium to rationally design further optimized vaccine conjugates.
 

Related news items


Camille Le Gall reports an efficient approach for delivery of poorly soluble tumor antigens to human cDC1s

20 April 2022

Camille Le Gall published about an efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion in the Journal of Immunotherapy of Cancer.

read more

Three VIDI grants for RIMLS researchers

24 May 2019

Matthijs Jore, Daniele Tauriello and Johannes Textor are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

read more

Publication on nanoparticle imaging agent

22 March 2019

Mangala Srinivas, theme Nanomedicine, showed in Advanced Functional Materials that nano‐particles (radius 100 nm), are suitable for long‐term in vivo ultrasound in combination with 19F MRI and fluorescence.

read more

RIMLS awards festival Twelve winners

16 January 2019

In 5 categories RIMLS young researchers received an award and bonus during the New Year's drinks. See all photo's.

read more

Rare immune cells kickstart anti-cancer immune response

3 September 2018

Florian Wimmers, theme Cancer development and immune defense, and colleagues developed a high-throughput nano lab to shed light on this process. Their findings were published in Nature Communications.

read more

ERA-NET grant on imaging in cardiovascular disease

3 November 2017

Subclinical atherosclerosis characterization: Nanoparticle-based molecular and cellular imaging (SCAN).

read more